Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. [electronic resource]
Producer: 20090608Description: 1167-77 p. digitalISSN:- 1558-8238
- Adult
- Antibodies, Monoclonal -- metabolism
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- metabolism
- Autoimmune Diseases -- therapy
- Blood Cell Count
- CD8-Positive T-Lymphocytes -- cytology
- Complement System Proteins -- immunology
- Cytotoxicity, Immunologic -- immunology
- Female
- Humans
- Immunity, Cellular -- immunology
- Immunotherapy -- adverse effects
- Infliximab
- Interferon-gamma -- metabolism
- Leukocytes, Mononuclear -- immunology
- Male
- Middle Aged
- Monocytes -- immunology
- Mycobacterium tuberculosis -- immunology
- Perforin
- Pore Forming Cytotoxic Proteins -- metabolism
- T-Lymphocyte Subsets -- cytology
- Tuberculosis -- immunology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Vesicular Transport Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.